Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection

Clinical trial NCT04170595 · UNKNOWN

Trial details

NCT number: NCT04170595
Sponsor: Genor Biopharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2014-03-28
Primary completion: 2021-12-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.